Alternate cell-death program identified

Harvard University's Junying Yuan and colleagues identified a chemical that blocks a programmed cell-death pathway that is non-apoptotic.

Written byMelissa Lee Phillips
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

© 2005 Nature Publishing Group

Harvard University's Junying Yuan and colleagues identified a chemical that blocks a programmed cell-death pathway that is non-apoptotic. Yuan's study1 shows that the chemical, necrostatin-1 (Nec-1), has no effect on apoptosis, only on this programmed necrosis-like death, which her team calls "necroptosis."

Apoptosis is triggered when ligands bind to members of the Fas/TNFR (tumor necrosis factor receptor) family of death-domain receptors, which turns on multiple caspases. But, the Fas/TNFR family can induce cell death even when caspase signaling, and therefore apoptosis, is inhibited. This cell death usually resembles necrosis rather than apoptosis.

Yuan's team screened approximately 15,000 compounds, looking for inhibitors of an alternate death pathway. When human cells were treated with tumor necrosis factor-α (a ligand for the Fas/TNFR family) and a pan-caspase inhibitor, most cells died a necrosis-like death, but one small molecule, Nec-1, prevented cells from dying. Nec-1 inhibits TNF-α-induced necrosis in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies